Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 14;14(1):253.
doi: 10.1186/s13023-019-1247-6.

Obesity in achondroplasia patients: from evidence to medical monitoring

Celine Saint-Laurent  1 , Laura Garde-Etayo  2 , Elvire Gouze  3   4
Affiliations
Review

Obesity in achondroplasia patients: from evidence to medical monitoring

Celine Saint-Laurent et al. Orphanet J Rare Dis. .

Abstract

Achondroplasia is a rare genetic disease representing the most common form of short-limb dwarfism. It is characterized by bone growth abnormalities that are well characterized and by a strong predisposition to abdominal obesity for which causes are unknown. Despite having aroused interest at the end of the 20 h century, there are still only very little data available on this aspect of the pathology. Today, interest is rising again, and some studies are now proposing mechanistic hypotheses and guidance for patient management. These data confirm that obesity is a major health problem in achondroplasia necessitating an early yet complex clinical management. Anticipatory care should be directed at identifying children who are at high risk to develop obesity and intervening to prevent the metabolic complications in adults. In this review, we are regrouping available data characterizing obesity in achondroplasia and we are identifying the current tools used to monitor obesity in these patients.

Keywords: Achondroplasia; Children; FGFR3; Nutrition; Obesity; Recommendations.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Horton WA, Hall JG, Hecht JT. Achondroplasia. Lancet. 2007;370(9582):162–172. doi: 10.1016/S0140-6736(07)61090-3. - DOI - PubMed
    1. Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 1994;371(6494):252–254. doi: 10.1038/371252a0. - DOI - PubMed
    1. Wilkin DJ, Szabo JK, Cameron R, Henderson S, Bellus GA, Mack ML, et al. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet. 1998;63(3):711–716. doi: 10.1086/302000. - DOI - PMC - PubMed
    1. Bellus GA, Hefferon TW, Ortiz de Luna RI, Hecht JT, Horton WA, Machado M, et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet. 1995;56(2):368–373. - PMC - PubMed
    1. Xue Y, Sun A, Mekikian PB, Martin J, Rimoin DL, Lachman RS, et al. FGFR3 mutation frequency in 324 cases from the international skeletal dysplasia registry. Mol Genet Genomic Med. 2014;2(6):497–503. doi: 10.1002/mgg3.96. - DOI - PMC - PubMed

Publication types

Substances